(3R)-1-azabicyclo[2.2.2]octan-3-yl (1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate, butanedioic acid(CAS: 862207-70-3)

The compound has a crystalline form and a molecular weight of approximately 567.5 g/mol. It is slightly soluble in water and has good solubility in organic solvents. Chemically, it is stable under normal conditions but can react with strong bases and acids. It is not flammable and has a low reactivity towards common reagents.

This compound is typically synthesized via a multi-step process involving the use of protecting groups, coupling reactions, and acid/base catalysis. The synthesis involves the formation of a protected azabicyclic intermediate, followed by coupling with the tetrahydroisoquinoline-2-carboxylate, and finally, deprotection to yield the target compound. The overall yield is moderate, around 50-70% depending on the specific reaction conditions.

This compound is primarily used in the pharmaceutical industry for drug development, particularly in the synthesis of novel therapeutic agents. It may also find applications in the polymer industry for the development of advanced materials. Due to its structural complexity, it is less commonly used in other industries such as sensors or semiconductors.

Proper personal protective equipment (PPE) should be worn, including gloves, safety goggles, and a lab coat. Work should be conducted in a fume hood to minimize exposure to vapors. Spills should be cleaned up using appropriate absorbent materials and the area should be well-ventilated. Always refer to the Safety Data Sheet (SDS) for detailed safety information and emergency procedures.